Private Equity Deal Spotlight | Weekly Update

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework.

Hall Render’s PE team of attorneys and advisors leverage the strength and depth of our bench to navigate and efficiently execute PE transactions. The summary below includes highlights of recent PE deals and legislative updates.

• THL Partners made a majority equity investment in Red Nucleus. Red Nucleus is a provider of specialized services, including training programs designed for pharmaceutical sales teams, clinical staff and health care professionals, throughout the life sciences industry. In addition, Red Nucleus assists pharmaceutical companies with market access and commercialization strategies to develop effective pricing and reimbursement plans. THL Partners is a PE firm based in Boston, Massachusetts that focuses on investments in middle-market growth companies across various sectors, including health care.
• Parkview Dental Partners, a leading dental support organization, announced the acquisition of Breezy Dental. Breezy Dental is a well-established dental practice located in Tampa, Florida. The acquisition strengthens Parkview Dental Partners’ presence in the Florida Gulf Coast region and enhances its ability to deliver high-quality patient care. Parkview Dental Partners is backed by Cathay Capital, a global PE firm that supports health care, technology and consumer companies around the world.
• Audax Private Equity completed the carve out of the clinical services business within Avantor, Inc. The clinical services business provides clinical trial and laboratory supply chain services to pharmaceutical and biotechnology companies throughout the United States. Following the carve out, Audax will rebrand the clinical services business as Resonant Clinical Solutions. Audax is a PE firm with offices in Boston, Massachusetts and San Francisco, California that manages approximately $19 billion in assets.
• Cold Chain Technology, a provider of advanced thermal packing and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, announced the acquisition of Tower Cold Chain. Tower Cold Chain is a global provider of advanced reusable cold chain solutions. Cold Chain Technology is backed by Aurora Capital Partners, a PE firm located in Los Angeles, California with roughly $6 billion in assets under management. The acquisition of Tower Cold Chain marks Cold Chain Technology’s fourth investment since partnering with Aurora Capital Partners in 2019.

If you have any questions or would like additional information, please contact: